Literature DB >> 25118160

Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening.

Fabrice Smieliauskas1, Heber MacMahon2, Ravi Salgia3, Ya-Chen Tina Shih4.   

Abstract

BACKGROUND: Newly released United States Preventive Services Task Force (USPSTF) recommendations for lung cancer screening are expected to increase demand for low-dose computed tomography scanning, but health system capacity constraints might threaten the scale-up of screening.
OBJECTIVES: To estimate the prevalence of capacity constraints in the radiologist workforce and resulting potential disparities in access to lung cancer screening.
METHODS: We combined information from health interview surveys to estimate the numbers of smokers who meet the USPSTF eligibility criteria, and information from administrative datasets to estimate the numbers of radiologists and the numbers of scans they currently interpret in Health Service Areas (HSAs) nationwide. We estimated and mapped the prevalence of capacity constrained HSAs - those having a greater than 5% or greater than 25% projected increase in scans over current levels from scaling up screening - and used descriptive statistics and logistic regressions to identify HSA characteristics associated with capacity constraints.
RESULTS: Scaling up lung cancer screening would increase imaging procedures by an average of 4% across HSAs. Of the 9.6 million eligible smokers, 1,023,943 lived in HSAs with increases of at least 5%. HSAs that were rural, with many eligible smokers, and disproportionately Hispanic or low-income smokers had significantly higher odds of facing capacity constraints.
CONCLUSIONS: Disparities in access to lung cancer screening appear likely unless policy makers target HSAs with few radiologists for additional resources. Radiologists should be able to absorb the workload imposed by lung cancer screening in most areas of the country.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  CT scan; cancer screening; health care capacity; lung cancer; radiologists

Mesh:

Year:  2014        PMID: 25118160      PMCID: PMC4407799          DOI: 10.1177/0969141314548055

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  24 in total

1.  Computed tomographic screening for lung cancer: current practice patterns at leading academic medical centers.

Authors:  Phillip M Boiselle; Charles S White; James G Ravenel
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

2.  Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Yingru Zhao; Xueqian Xie; Ernst Th Scholten; Willem Mali; Erik Thunnissen; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Kristiaan Nackaerts; Joost van Rosmalen; Matthijs Oudkerk; Harry J de Koning
Journal:  Eur Respir J       Date:  2013-07-11       Impact factor: 16.671

3.  The sharp slowdown in growth of medical imaging: an early analysis suggests combination of policies was the cause.

Authors:  David W Lee; Frank Levy
Journal:  Health Aff (Millwood)       Date:  2012-07-25       Impact factor: 6.301

4.  Initial experience with a free, high-volume, low-dose CT lung cancer screening program.

Authors:  Brady J McKee; Andrea B McKee; Sebastian Flacke; Carla R Lamb; Paul J Hesketh; Christoph Wald
Journal:  J Am Coll Radiol       Date:  2013-04-26       Impact factor: 5.532

5.  Controversies in lung cancer screening.

Authors:  Ritu R Gill; Michael T Jaklitsch; Francine L Jacobson
Journal:  J Am Coll Radiol       Date:  2013-12       Impact factor: 5.532

6.  Annual number of lung cancer deaths potentially avertable by screening in the United States.

Authors:  Jiemin Ma; Elizabeth M Ward; Robert Smith; Ahmedin Jemal
Journal:  Cancer       Date:  2013-02-25       Impact factor: 6.860

Review 7.  American Cancer Society lung cancer screening guidelines.

Authors:  Richard Wender; Elizabeth T H Fontham; Ermilo Barrera; Graham A Colditz; Timothy R Church; David S Ettinger; Ruth Etzioni; Christopher R Flowers; G Scott Gazelle; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Daniel C Sullivan; William Travis; Louise Walter; Andrew M D Wolf; Otis W Brawley; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2013-01-11       Impact factor: 508.702

8.  Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.

Authors:  Bernardo H L Goulart; Scott D Ramsey
Journal:  Oncologist       Date:  2013-07-19

9.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

Authors:  Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

View more
  12 in total

1.  Rural-Urban Differences in Cancer Incidence and Trends in the United States.

Authors:  Whitney E Zahnd; Aimee S James; Wiley D Jenkins; Sonya R Izadi; Amanda J Fogleman; David E Steward; Graham A Colditz; Laurent Brard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-27       Impact factor: 4.254

2.  Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization.

Authors:  Ruth C Carlos; JoRean D Sicks; Caroline Chiles; Lucy Gansauer; Charles S Kamen; Anne E Kazak; Heather B Neuman; Joseph M Unger; Kathryn E Weaver
Journal:  J Am Coll Radiol       Date:  2019-02-26       Impact factor: 5.532

3.  Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.

Authors:  David H Howard; Thomas B Richards; Peter B Bach; Michelle C Kegler; Carla J Berg
Journal:  Cancer       Date:  2015-09-15       Impact factor: 6.860

4.  Access to Lung Cancer Screening Services: Preliminary Analysis of Geographic Service Distribution Using the ACR Lung Cancer Screening Registry.

Authors:  Paniz Charkhchi; Giselle E Kolenic; Ruth C Carlos
Journal:  J Am Coll Radiol       Date:  2017-11       Impact factor: 5.532

5.  Deep learning is effective for the classification of OCT images of normal versus Age-related Macular Degeneration.

Authors:  Cecilia S Lee; Doug M Baughman; Aaron Y Lee
Journal:  Ophthalmol Retina       Date:  2017-02-13

6.  Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: a simulation modelling study.

Authors:  Angela C Tramontano; Deirdre F Sheehan; Pamela M McMahon; Emily C Dowling; Theodore R Holford; Karen Ryczak; Samuel M Lesko; David T Levy; Chung Yin Kong
Journal:  BMJ Open       Date:  2016-02-29       Impact factor: 2.692

7.  Treatment capacity required for full-scale implementation of lung cancer screening in the United States.

Authors:  Erik F Blom; Kevin Ten Haaf; Douglas A Arenberg; Harry J de Koning
Journal:  Cancer       Date:  2019-02-27       Impact factor: 6.860

Review 8.  Clinical Implementation of Deep Learning in Thoracic Radiology: Potential Applications and Challenges.

Authors:  Eui Jin Hwang; Chang Min Park
Journal:  Korean J Radiol       Date:  2020-05       Impact factor: 3.500

9.  Geographic Variations and Time Trends in Cancer Treatments in Taiwan.

Authors:  Jason C Hsu; Sheng-Mao Chang; Christine Y Lu
Journal:  BMC Public Health       Date:  2017-08-02       Impact factor: 3.295

10.  Rural areas are disproportionately impacted by smoking and lung cancer.

Authors:  Wiley D Jenkins; Alicia K Matthews; Angie Bailey; Whitney E Zahnd; Karriem S Watson; Georgia Mueller-Luckey; Yamile Molina; David Crumly; Julie Patera
Journal:  Prev Med Rep       Date:  2018-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.